Literature DB >> 32561075

Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.

Feng Xue1, Yong Jia2, Jian Zhao3.   

Abstract

BACKGROUND: Tyrosine-protein kinase Fyn (FYN) plays a crucial role in Src family, which participates in the signal transduction of brain nerves and the development and activation of T lymphocytes in physiological conditions. We probed into the roles and mechanisms of FYN in lung adenocarcinoma (LUAD).
METHODS: Cell activity, apoptosis, invasion, and migration were detected by CCK-8, FCM, transwell, and wound-healing assays, respectively. The angiogenesis capacity was evaluated by in vitro angiogenesis test. Relative mRNA and protein expressions were determined by qRT-PCR, Western blot, and immunohistochemistry assays, respectively. Insulin-like growth factors-I (IGF-I) was used as an agonist of PI3K/AKT pathway.
RESULTS: We demonstrated that FYN expression correlated with LUAD prognosis and was down-regulated in LUAD tissues and LUAD cells. Overexpression of FYN suppressed the cell viability, together with invasion and migration abilities of A549 cells. FYN overexpression accelerated the cell apoptosis and reduced the angiogenesis capacity of A549 cells. Overexpression of FYN suppressed E-cadherin, Vimentin, Snail, and PI3K/AKT expressions in A549 cells. High expression level of FYN reduced the migration and invasion capacities of A549 cells via down-regulating the PI3K/AKT pathway.
CONCLUSION: Collectively, our findings reveal that overexpression of FYN inhibits the epithelial-to-mesenchymal transition (EMT) through down-regulating the PI3K/AKT pathway in A549 cells.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A549; AKT; FYN; IGF-I; Lung adenocarcinoma; PI3K

Mesh:

Substances:

Year:  2020        PMID: 32561075     DOI: 10.1016/j.suronc.2020.02.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  4 in total

1.  PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.

Authors:  Sheng Sun; Yiyang Liu; Meiling Zhou; Jinyuan Wen; Lin Xue; Shenqi Han; Junnan Liang; Yufei Wang; Yi Wei; Jinjin Yu; Xin Long; Xiaoping Chen; Huifang Liang; Zhao Huang; Bixiang Zhang
Journal:  Cell Biosci       Date:  2022-05-07       Impact factor: 7.133

2.  Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.

Authors:  Yunliang Tang; Yanxia Jiang; Cheng Qing; Jiao Wang; Zhenguo Zeng
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

3.  METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.

Authors:  Yuntao Shi; Yingying Zhuang; Jialing Zhang; Mengxue Chen; Shangnong Wu
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

4.  c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment.

Authors:  José A López-Mejía; Luis F Tallabs-Utrilla; Pablo Salazar-Sojo; Jessica C Mantilla-Ollarves; Manuel A Sánchez-Carballido; Leticia Rocha-Zavaleta
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.